The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b study of the anti-PD-1 monoclonal antibody BGB-A317 (A317) in combination with the PARP inhibitor BGB-290 (290) in advanced solid tumors.
 
Michael Friedlander
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - AstraZeneca; Pfizer
 
Tarek Meniawy
Research Funding - BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Roche
 
Ben Markman
Travel, Accommodations, Expenses - BeiGene
 
Linda R. Mileshkin
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Roche; Roche
 
Paul R. Harnett
Patents, Royalties, Other Intellectual Property - Westmead Hospital (Inst)
Expert Testimony - Apotex
 
Michael Millward
Research Funding - BeiGene (Inst)
 
Joanne Lundy
No Relationships to Disclose
 
Alison E. Freimund
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Christie Norris
No Relationships to Disclose
 
Song Mu
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
John Wu
Employment - Beigene
 
Virginia E. Paton
Employment - BeiGene; Medivation
Stock and Other Ownership Interests - BeiGene
 
Lai Wang
Employment - BeiGene
Leadership - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Bo Gao
No Relationships to Disclose